Skip to main content

Epizyme, Inc.

EPZMDelisted Aug 12, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001571498

Epizyme, Inc. was delisted on Aug 12, 2022; its insiders filed their last Form 4 on Aug 16, 2022; 94 institutions reported holding it in 13F filings for Q2 2022, worth $187.0M in total; no superinvestor held it.

13F holders, Q4 2021

Institutional positions in Epizyme, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
132
+17 vs. Q3 2021
Shares held
84.8M
−5.06M (−5.6%) vs. Q3 2021
Total value
$212.1M
−$248.1M (−53.9%) vs. Q3 2021
New holders
37
39 more added
Sold out
20
36 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting EPZM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 132 institutions
Q1 2021: 140 institutionsQ2 2021: 127 institutionsQ3 2021: 116 institutionsQ4 2021: 132 institutionsQ1 2022: 120 institutionsQ2 2022: 94 institutionsQ3 2022: 1 institutionQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $212.1M
Q1 2021: $838.5MQ2 2021: $790.2MQ3 2021: $479.9MQ4 2021: $212.1MQ1 2022: $177.5MQ2 2022: $187.0MQ3 2022: $4.00KQ4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding EPZM and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20221$4.00K
Q2 202294$187.0M
Q1 2022120$177.5M
Q4 2021132$212.1M
Q3 2021116$479.9M
Q2 2021127$790.2M
Q1 2021140$838.5M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Epizyme, Inc.; share changes are against Q3 2021.

Institutions holding EPZM in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Hennion & Walsh Asset Management, Inc.346,830$867.0K0.04%−97,168−21.9%Reduced
ExodusPoint Capital Management, LP359,472$899.0K0.01%+359,472New
Healthcare of Ontario Pension Plan Trust Fund403,200$1.01M0.00%+403,200New
Redmile Group, LLC454,475$1.14M0.03%−7,004,185−93.9%Reduced
BNP Paribas Arbitrage, SA482,794$1.21M0.00%+466,413+2,847.3%Added
Renaissance Technologies LLC509,188$1.27M0.00%+509,188New
HRT Financial LP567,836$1.42M0.01%+458,308+418.4%Added
Assenagon Asset Management S.A.576,484$1.44M0.01%+359,464+165.6%Added
Jacobs Levy Equity Management, Inc587,164$1.47M0.01%+587,164New
Charles Schwab Investment Management Inc637,481$1.59M0.00%+8,403+1.3%Added
Foresite Capital Management II, LLC690,002$1.73M0.66%−142,334−17.1%Reduced
Frazier Management LLC739,369$1.85M0.14%00.0%Unchanged
Citadel Advisors LLC776,335$1.94M0.00%+736,685+1,858.0%Added
Morgan Stanley788,360$1.97M0.00%−1,920,113−70.9%Reduced
Norges Bank818,853$2.05M0.00%+72,475+9.7%Added
FMR LLC865,373$2.16M0.00%−934,744−51.9%Reduced
CIBC Private Wealth Group, LLC882,000$2.21M0.00%−832,500−48.6%Reduced
Northern Trust Corp948,546$2.37M0.00%+12,285+1.3%Added
Two Sigma Investments, LP1,022,627$2.56M0.01%+1,010,627+8,421.9%Added
Geode Capital Management, LLC1,658,936$4.15M0.00%−34,581−2.0%Reduced
State Street Corp1,840,529$4.60M0.00%−4,187,682−69.5%Reduced
Millennium Management LLC1,954,128$4.88M0.01%+1,532,196+363.1%Added
Platinum Investment Management Ltd2,822,936$7.06M0.20%+919,043+48.3%Added
Bank of America Corp2,955,970$7.39M0.00%+2,912,277+6,665.3%Added
Goldman Sachs Group Inc3,262,543$8.16M0.00%+2,690,437+470.3%Added
MPM Oncology Impact Management LP3,425,202$8.56M1.56%−547,628−13.8%Reduced
Rock Springs Capital Management LP3,807,662$9.52M0.22%+213,777+5.9%Added
Palo Alto Investors LP5,485,213$13.7M0.88%−1,371,300−20.0%Reduced
Vanguard Group Inc5,984,908$15.0M0.00%−1,873,365−23.8%Reduced
BlackRock Inc.7,615,648$19.0M0.00%+71,289+0.9%Added
RP Management, LLC9,166,667$22.9M10.46%00.0%Unchanged
Primecap Management Co15,366,477$38.4M0.03%+56,100+0.4%Added
Foresite Capital Management III, LLC0$00.00%−998,278−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−238,344−100.0%Sold out
Duality Advisers, LP0$00.00%−133,513−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−107,566−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−66,329−100.0%Sold out
Woodstock Corp0$00.00%−62,183−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−61,853−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−51,919−100.0%Sold out
Caption Management, LLC0$00.00%−44,445−100.0%Sold out
DekaBank Deutsche Girozentrale0$00.00%−32,300−100.0%Sold out
Sage Mountain Advisors LLC0$00.00%−24,273−100.0%Sold out
Handelsbanken Fonder AB0$00.00%−23,400−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−13,338−100.0%Sold out
Simplex Trading, LLC0$00.00%−7,717−100.0%Sold out
Cambridge Investment Research Advisors, Inc.0$00.00%−12,500−100.0%Sold out
Bridgefront Capital, LLC0$00.00%−10,932−100.0%Sold out
Penserra Capital Management LLC0$00.00%−2,340−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−1,512−100.0%Sold out
Parkside Financial Bank & Trust0$00.00%−530−100.0%Sold out
Harbour Investments, Inc.0$00.00%−200−100.0%Sold out
KPCB XIII Associates, LLC––––Not filed